Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 91395301000001119 | Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 91395401000001110 | Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Is a | Salbutamol+ipratropium bromide 2.5mg/500micrograms nebulization unit | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Has active ingredient | Salbutamol | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Has active ingredient | Ipratropium bromide | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Has manufactured dose form | Inhalation dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Has specific active ingredient | Salbutamol sulfate | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Has specific active ingredient | Ipratropium bromide | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Has dispensed dose form | Nebulizer liquid | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Salbutamol | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Has basis of strength substance | Salbutamol | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) 60 unit dose | Has AMP | False | Salbutamol 2.5mg/2.5ml / Ipratropium bromide 500micrograms/2.5ml nebuliser liquid unit dose vials (Ennogen Healthcare Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR